BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gibbons CH, Garcia J, Wang N, Shih LC, Freeman R. The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease. Neurology 2016;87:505-12. [PMID: 27385742 DOI: 10.1212/WNL.0000000000002919] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Nishiwaki H, Ito M, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Yoshida T, Hanada H, Takeuchi I, Katsuno M, Hirayama M, Ohno K. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease. NPJ Parkinsons Dis 2022;8:65. [PMID: 35650236 DOI: 10.1038/s41531-022-00328-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Khemani P, Elliott M, Levine T. An atypical clinical course of a 71-year-old man with right arm weakness and ataxia. Parkinsonism Relat Disord 2022:S1353-8020(22)00043-8. [PMID: 35504790 DOI: 10.1016/j.parkreldis.2022.02.010] [Reference Citation Analysis]
3 Scott GD, Arnold MR, Beach TG, Gibbons CH, Kanthasamy AG, Lebovitz RM, Lemstra AW, Shaw LM, Teunissen CE, Zetterberg H, Taylor AS, Graham TC, Boeve BF, Gomperts SN, Graff-radford NR, Moussa C, Poston KL, Rosenthal LS, Sabbagh MN, Walsh RR, Weber MT, Armstrong MJ, Bang JA, Bozoki AC, Domoto-reilly K, Duda JE, Fleisher JE, Galasko DR, Galvin JE, Goldman JG, Holden SK, Honig LS, Huddleston DE, Leverenz JB, Litvan I, Manning CA, Marder KS, Pantelyat AY, Pelak VS, Scharre DW, Sha SJ, Shill HA, Mari Z, Quinn JF, Irwin DJ. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. Front Neurol 2022;12:805135. [DOI: 10.3389/fneur.2021.805135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Vacchi E, Senese C, Chiaro G, Disanto G, Pinton S, Morandi S, Bertaina I, Bianco G, Staedler C, Galati S, Gobbi C, Kaelin-Lang A, Melli G. Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's disease. NPJ Parkinsons Dis 2021;7:119. [PMID: 34930911 DOI: 10.1038/s41531-021-00262-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kuzkina A, Bargar C, Schmitt D, Rößle J, Wang W, Schubert AL, Tatsuoka C, Gunzler SA, Zou WQ, Volkmann J, Sommer C, Doppler K, Chen SG. Diagnostic value of skin RT-QuIC in Parkinson's disease: a two-laboratory study. NPJ Parkinsons Dis 2021;7:99. [PMID: 34782640 DOI: 10.1038/s41531-021-00242-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
6 Nakagaki T, Nishida N, Satoh K. Development of α-Synuclein Real-Time Quaking-Induced Conversion as a Diagnostic Method for α-Synucleinopathies. Front Aging Neurosci 2021;13:703984. [PMID: 34650422 DOI: 10.3389/fnagi.2021.703984] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Evidente VGH, Evidente DH, Ortega SC, Levine TD, Freeman R, Gibbons C. X-Linked Dystonia-Parkinsonism ("Lubag") May Present with Peripheral Synucleinopathy. Mov Disord 2021. [PMID: 34582053 DOI: 10.1002/mds.28801] [Reference Citation Analysis]
8 Oliveira LMA, Gasser T, Edwards R, Zweckstetter M, Melki R, Stefanis L, Lashuel HA, Sulzer D, Vekrellis K, Halliday GM, Tomlinson JJ, Schlossmacher M, Jensen PH, Schulze-Hentrich J, Riess O, Hirst WD, El-Agnaf O, Mollenhauer B, Lansbury P, Outeiro TF. Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease. NPJ Parkinsons Dis 2021;7:65. [PMID: 34312398 DOI: 10.1038/s41531-021-00203-9] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
9 Ganguly U, Singh S, Pal S, Prasad S, Agrawal BK, Saini RV, Chakrabarti S. Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough. Front Aging Neurosci 2021;13:702639. [PMID: 34305577 DOI: 10.3389/fnagi.2021.702639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dean DN, Lee JC. Linking Parkinson's Disease and Melanoma: Interplay Between α-Synuclein and Pmel17 Amyloid Formation. Mov Disord 2021;36:1489-98. [PMID: 34021920 DOI: 10.1002/mds.28655] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Bargar C, Wang W, Gunzler SA, LeFevre A, Wang Z, Lerner AJ, Singh N, Tatsuoka C, Appleby B, Zhu X, Xu R, Haroutunian V, Zou WQ, Ma J, Chen SG. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol Commun 2021;9:62. [PMID: 33827706 DOI: 10.1186/s40478-021-01175-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
12 Levine TD, Bellaire B, Gibbons C, Freeman R. Cutaneous alpha-synuclein deposition in postural tachycardia patients. Ann Clin Transl Neurol 2021;8:908-17. [PMID: 33764697 DOI: 10.1002/acn3.51347] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Nishiwaki H, Hamaguchi T, Ito M, Ishida T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder. mSystems 2020;5:e00797-20. [PMID: 33293403 DOI: 10.1128/mSystems.00797-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang Z, Becker K, Donadio V, Siedlak S, Yuan J, Rezaee M, Incensi A, Kuzkina A, Orrú CD, Tatsuoka C, Liguori R, Gunzler SA, Caughey B, Jimenez-Capdeville ME, Zhu X, Doppler K, Cui L, Chen SG, Ma J, Zou WQ. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol 2020. [PMID: 32986090 DOI: 10.1001/jamaneurol.2020.3311] [Cited by in Crossref: 17] [Cited by in F6Publishing: 54] [Article Influence: 8.5] [Reference Citation Analysis]
15 Manne S, Kondru N, Jin H, Serrano GE, Anantharam V, Kanthasamy A, Adler CH, Beach TG, Kanthasamy AG. Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients. Mov Disord 2020;35:2230-9. [PMID: 32960470 DOI: 10.1002/mds.28242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
16 Wang N, Garcia J, Freeman R, Gibbons CH. Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results. J Histochem Cytochem 2020;68:669-78. [PMID: 32921251 DOI: 10.1369/0022155420960250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
17 Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL 3rd, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, Kopil CM, Riley L, Dave KD, Mollenhauer B; Systemic Synuclein Sampling Study. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology 2020;95:e1267-84. [PMID: 32747521 DOI: 10.1212/WNL.0000000000010404] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 12.5] [Reference Citation Analysis]
18 Mazzetti S, Basellini MJ, Ferri V, Cassani E, Cereda E, Paolini M, Calogero AM, Bolliri C, De Leonardis M, Sacilotto G, Cilia R, Cappelletti G, Pezzoli G. α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson's disease. Brain 2020;143:920-31. [PMID: 32025699 DOI: 10.1093/brain/awaa008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
19 Kilzheimer A, Hentrich T, Burkhardt S, Schulze-Hentrich JM. The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife. Front Neurol 2019;10:1328. [PMID: 31920948 DOI: 10.3389/fneur.2019.01328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Isonaka R, Rosenberg AZ, Sullivan P, Corrales A, Holmes C, Sharabi Y, Goldstein DS. Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension. Hypertension 2019;73:910-8. [PMID: 30798661 DOI: 10.1161/HYPERTENSIONAHA.118.12642] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
21 Zhang LM, Wang MH, Yang HC, Tian T, Sun GF, Ji YF, Hu WT, Liu X, Wang JP, Lu H. Dopaminergic neuron injury in Parkinson's disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/ α-synuclein pathway. Aging (Albany NY) 2019;11:9264-79. [PMID: 31683259 DOI: 10.18632/aging.102330] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
22 Isonaka R, Gibbons CH, Wang N, Freeman R, Goldstein DS. Association of innervation-adjusted alpha-synuclein in arrector pili muscles with cardiac noradrenergic deficiency in autonomic synucleinopathies. Clin Auton Res 2019;29:587-93. [PMID: 31673840 DOI: 10.1007/s10286-019-00644-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL 3rd, Schneider J, Crary JF, Sue LI, Adler CH, Glass MJ, Intorcia AJ, Walker JE, Foroud T, Coffey CS, Ecklund D, Riss H, Goßmann J, König F, Kopil CM, Arnedo V, Riley L, Linder C, Dave KD, Jennings D, Seibyl J, Mollenhauer B, Chahine L; Systemic Synuclein Sampling Study (S4). Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4). J Neuropathol Exp Neurol 2018;77:793-802. [PMID: 30107604 DOI: 10.1093/jnen/nly056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
24 Mendoza-Velásquez JJ, Flores-Vázquez JF, Barrón-Velázquez E, Sosa-Ortiz AL, Illigens BW, Siepmann T. Autonomic Dysfunction in α-Synucleinopathies. Front Neurol 2019;10:363. [PMID: 31031694 DOI: 10.3389/fneur.2019.00363] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
25 Metzger JM, Emborg ME. Autonomic dysfunction in Parkinson disease and animal models. Clin Auton Res 2019;29:397-414. [PMID: 30604165 DOI: 10.1007/s10286-018-00584-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
26 Kim JY, Illigens BM, McCormick MP, Wang N, Gibbons CH. Alpha-Synuclein in Skin Nerve Fibers as a Biomarker for Alpha-Synucleinopathies. J Clin Neurol 2019;15:135-42. [PMID: 30938106 DOI: 10.3988/jcn.2019.15.2.135] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
27 Donadio V. Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review. Clin Auton Res 2019;29:577-85. [PMID: 30506233 DOI: 10.1007/s10286-018-0581-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
28 Gibbons CH, Wang N, Freeman R. Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson's Disease. J Parkinsons Dis 2017;7:503-9. [PMID: 28582870 DOI: 10.3233/JPD-171088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
29 Siepmann T, Penzlin AI, Illigens BM, Reichmann H. Should Skin Biopsies Be Performed in Patients Suspected of Having Parkinson's Disease? Parkinsons Dis 2017;2017:6064974. [PMID: 29214093 DOI: 10.1155/2017/6064974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
30 Chahine LM, Stern MB. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next? Mov Disord Clin Pract 2017;4:796-805. [PMID: 30363472 DOI: 10.1002/mdc3.12545] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Picillo M, Barone P, Pellecchia MT. Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease. Mov Disord Clin Pract 2017;4:652-62. [PMID: 30363377 DOI: 10.1002/mdc3.12521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, Goldstein DS, Peltier AC, Shibao CA, Gibbons CH, Freeman R, Robertson D; Autonomic Disorders Consortium. Natural history of pure autonomic failure: A United States prospective cohort. Ann Neurol 2017;81:287-97. [PMID: 28093795 DOI: 10.1002/ana.24877] [Cited by in Crossref: 138] [Cited by in F6Publishing: 146] [Article Influence: 27.6] [Reference Citation Analysis]
33 Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease. Acta Neuropathol 2017;133:535-45. [PMID: 28180961 DOI: 10.1007/s00401-017-1684-z] [Cited by in Crossref: 150] [Cited by in F6Publishing: 131] [Article Influence: 30.0] [Reference Citation Analysis]
34 Jankovic J. Movement disorders in 2016: Progress in Parkinson disease and other movement disorders. Nat Rev Neurol 2017;13:76-8. [PMID: 28084323 DOI: 10.1038/nrneurol.2016.204] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
35 Yarns BC, Glass OM. Why Trainees Should Consider a Career in Geriatric Psychiatry: Reflections From Two AAGP Trainee Board Members. Am J Geriatr Psychiatry 2017;25:204-6. [PMID: 28040428 DOI: 10.1016/j.jagp.2016.11.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Titova N, Padmakumar C, Lewis SJG, Chaudhuri KR. Parkinson's: a syndrome rather than a disease? J Neural Transm (Vienna) 2017;124:907-14. [PMID: 28028643 DOI: 10.1007/s00702-016-1667-6] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 15.3] [Reference Citation Analysis]
37 Siepmann T, Illigens BM, Barlinn K. Alpha-synuclein in cutaneous small nerve fibers. Neuropsychiatr Dis Treat 2016;12:2731-5. [PMID: 27822045 DOI: 10.2147/NDT.S117423] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]